BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Recs

0
Player Avatar EBStroke (< 20) Submitted: 8/11/2012 2:43:25 AM : Underperform Start Price: $3.95 BCRX Score: +10.73

Zacks Rank 3-Hold, Recommend Neutral, Industry Rank 75 / 265, Target 4.90, Avg target of 3 analysts 7.67

- set limit lid @ 4.12 (+.10)

Featured Broker Partners


Advertisement